New management algorithm for acute post cataract endophthalmitis
2 February 2024
| Su Young
|
EYE - Cataract, EYE - Refractive
|
Bacteria, cataract, endophthalmitis, infection, pseudophakia, vitrectomy
In this study, the authors aimed to establish an objective algorithm for recommending urgent pars plana vitrectomy (PPV) to help improve visual outcomes in the current era of clear corneal-incision phacoemulsification and small gauge PPV. This study examined 150 cases...
Practice patterns in managing exogenous endophthalmitis
1 December 2022
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Global practice patterns, endophthalmitis, exogenous endophthalmitis, ophthalmology
The authors of this study conducted a global survey of medical institutions regarding management of exogenous endophthalmitis to assess current practice patterns for this sight-threatening emergency. Thirty-six (of 42 institutions) responded and were included in the analysis. Results were as...
Clinical features and mortality of endogenous panophthalmitis in China
1 June 2022
| Su Young
|
EYE - Vitreo-Retinal
|
Endogenous endophthalmitis, Endogenous panophthalmitis, Interdisciplinary cooperation, Klebsiella pneumoniae, Pyogenic liver abscess
This longitudinal cohort study aimed to report the clinical features, treatment strategy, and mortality of 15 consecutive patients (16 eyes) with endogenous panophthalmitis (EP) at a tertiary medical centre of the largest eye centre in Northern China. Mean age was...
Incidence and outcomes of endophthalmitis with in-house compounded intravitreal bevacizumab injections
1 December 2021
| Su Young
|
EYE - Vitreo-Retinal
|
IVI, In-house compounded, bevacizumab, compounding pharmacy, endophthalmitis
This multicentre study examining a five-year period from 2014 to 2018 evaluated the incidence rate and outcomes of endophthalmitis after intravitreal injection of in-house compounded bevacizumab. In-house compounded syringes were prepared in compounding pharmacy using sterile standard operating guidelines. All...
Should intravitreal steroids be used in the initial treatment of post-op endophthalmitis?
1 October 2018
| Eulee Seow
|
EYE - Cataract, EYE - Refractive
|
adjuvant intravitreal dexamethasone, cataract surgery, postoperative bacterial endophthalmitis, randomized controlled trial
Endophthalmitis following cataract surgery is one of the most feared complications, and can have significant impact on the visual outcomes of patients. The role of steroids in the management of endopthalmitis is controversial. The aim of this paper was to...
Clinical characteristics and outcomes of open globe injury
1 December 2015
| Anjali Gupta
|
EYE - Cornea, EYE - General
|
endophthalmitis, open eye injury, penetrating eye injury, wound leak
This retrospective cohort study examined consecutive open globe injuries at a tertiary referral centre over a three year period. The aim of the study was to detail the clinical characteristics of open globe injuries and to explore their association with...
Nasolacrimal duct screening to minimise post cataract endophthalmitis
1 February 2015
| Anjali Gupta
|
EYE - Cataract, EYE - Refractive
|
cataract, endophthalmitis, nasolacrimal duct obstruction
This case control study compared the nasolacrimal duct (NLD) patency in a random sample of phacoemulsification cataract surgery patients (control group) versus a consecutive series of patients who developed endophthalmitis post cataract surgery (case group). NLD syringing was performed in...
